Journal Article Summary
The article investigates how intrauterine growth restriction (IUGR) affects cardiovascular health, particularly focusing on male offspring. This topic is significant because IUGR can lead to long-term health issues, including high blood pressure, which is a major risk factor for cardiovascular diseases. Understanding the mechanisms behind these changes can help in developing strategies to mitigate risks associated with IUGR.
The researchers conducted a study comparing male offspring that experienced IUGR with age-matched control offspring. They found that the blood pressure of growth-restricted males was significantly higher at 12 months of age compared to controls, but this difference was not present at 18 months. Interestingly, while blood pressure increased in control offspring from 12 to 18 months, it remained stable in the growth-restricted group. The study also noted that testosterone levels did not correlate with blood pressure in the growth-restricted offspring at 12 months, suggesting different underlying mechanisms for hypertension at various ages.
However, the study has limitations, including a focus solely on male offspring, which may not represent the effects on females. Additionally, the research indicates that the causes of high blood pressure in growth-restricted offspring change as they age, which may complicate treatment approaches. Patients and caregivers should discuss these findings with healthcare professionals, especially regarding monitoring blood pressure and cardiovascular health in children with a history of IUGR, to ensure appropriate preventive measures are taken.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Dasinger John Henry, Intapad Suttira, Backstrom Miles A., Carter Anthony J., Alexander Barbara T.. Intrauterine growth restriction programs an accelerated age-related increase in cardiovascular risk in male offspring. American Journal of Physiology – Renal Physiology 2016. DOI: 10.1152/ajprenal.00123.2016. PMID: 27147668. PMCID: PMC5005278.
Featured Pill Pals Product
Enalapril Maleate 2.5 mg Tablets --- Generic For Vasotec --- SOLCO
Enalapril Maleate 2.5 mg Tablets — Generic For Vasotec — SOLCO is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
